WALTHAM, Mass., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) (“the Company”) today provided an update on injection kits supplied by Apellis and an update on the rare ...
People with adrenal insufficiency should be issued with emergency kits containing steroid injections to avoid hospital admission, NICE has recommended. Two or three kits should be provided to people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback